Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sunder Biomedical Tech CoROCO:4115 +0.38%52 Net Margin % is 0.92% as of Dec. 2025, which is 37% below its 10-year median of 1.45. GuruFocus rates ROCO:4115 with a GF Score™ of 52/100 and a GF Value™ of NT$10.70 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 818 Medical Devices & Instruments companies, Sunder Biomedical Tech Co ranks worse than 55.99% on this metric.
The historical rank and industry rank for Sunder Biomedical Tech Co's Net Margin % or its related term are showing as below:
ROCO:4115'
s Net Margin % Range Over the Past 10 Years
Min: -4.3 Med: 1.45 Max: 6.24
Current: -2.16
ROCO:4115's Net Margin % is ranked worse than 55.99% of 818
companies
in the Medical Devices & Instruments industry
Industry Median: 2.045
vs ROCO:4115: -2.16
Sunder Biomedical Tech Co (ROCO:4115) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Sunder Biomedical Tech Co Net Margin % Related Terms
Sunder Biomedical Tech Co Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4115 vs ISRG, BDX, MDLN: Net Margin % Comparison
For the Medical Instruments & Supplies subindustry, Sunder Biomedical Tech Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sunder Biomedical Tech Co Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sunder Biomedical Tech Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where Sunder Biomedical Tech Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sunder Biomedical Tech Co (ROCO:4115) has a Net Margin % of 0.92% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Sunder Biomedical Tech Co and its competitors. This is 37% below median its historical median of 1.45. According to the industry distribution chart, Sunder Biomedical Tech Co ranks #458 out of 818 companies in the Medical Devices & Instruments industry, placing it in the top 56%.
Is Sunder Biomedical Tech Co's Net Margin % too high?
Sunder Biomedical Tech Co's current Net Margin % of 0.92% is 37% below median its 10-year median of 1.45. The Medical Devices & Instruments industry median Net Margin % is 2.05. Sunder Biomedical Tech Co's value of 0.92% is 55% below this industry median. Based on the distribution chart, Sunder Biomedical Tech Co ranks #458 out of 818 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Sunder Biomedical Tech Co has a GF Score™ of 52/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sunder Biomedical Tech Co's Net Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Sunder Biomedical Tech Co ranks #458 out of 818 companies for Net Margin %. This places Sunder Biomedical Tech Co in the lower half of its industry. The industry median Net Margin % is 2.05. Sunder Biomedical Tech Co's value of 0.92% is 55% below this benchmark. While the company's 10-year median is 1.45 vs. the industry median of 2.05, Sunder Biomedical Tech Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.05, based on 818 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sunder Biomedical Tech Co's current Net Margin % of 0.92% is 55% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Sunder Biomedical Tech Co and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sunder Biomedical Tech Co's current Net Margin % is 0.92%, which is 37% below median its own 10-year median of 1.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunder Biomedical Tech Co stock overvalued right now?
Based on GuruFocus' analysis, Sunder Biomedical Tech Co (ROCO:4115) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$10.70, compared to a current price of NT$7.86 — trading 26.5% below its estimated fair value. The current Net Margin % is 0.92%, which is 37% below median its 10-year median of 1.45 and 55% below the Medical Devices & Instruments industry median of 2.05. Sunder Biomedical Tech Co's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Sunder Biomedical Tech Co (ROCO:4115), the current Net Margin % is 0.92% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sunder Biomedical Tech Co (ROCO:4115) Overvalued in 2026?
Based on GuruFocus' analysis, Sunder Biomedical Tech Co stock appears to be undervalued.
The current stock price of NT$7.86 is trading 26.5% below its estimated GF Value™ of NT$10.70.
GuruFocus considers Sunder Biomedical Tech Co to be Modestly Undervalued.
Key valuation signals for ROCO:4115:
Net Margin %: 0.92% (37% below median its 10-year median of 1.45)
GF Value™: NT$10.70 vs. price of NT$7.86 (26.5% below fair value)
Industry Position: 55% below the Medical Devices & Instruments median (#458 of 818)
No single metric tells the full story. See the ROCO:4115 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sunder Biomedical Tech Co Ltd is engaged in providing medical devices. Its products include Protective Goggles; Meltblown Nonwoven Fabric/Mask; Suction Irrigation Set; Smoke Filter; Endo Bag; Blood Line Set for Hemodialysis and others.
52GF Score
Get the complete analysis for ROCO:4115
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4115 has been successfully added to your 
